Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Hodgkin Lymphoma
• Lymphoma
• Medulloblastoma
• Neuroblastoma
• Non-hodgkin Lymphoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: University of Virginia | Conditions: Lymphoma, Childhood Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2024-05-06